Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

RAPGEF5 Regulates Nuclear Translocation of β-Catenin.

Developmental cell | 2018

Canonical Wnt signaling coordinates many critical aspects of embryonic development, while dysregulated Wnt signaling contributes to common diseases, including congenital malformations and cancer. The nuclear localization of β-catenin is the defining step in pathway activation. However, despite intensive investigation, the mechanisms regulating β-catenin nuclear transport remain undefined. In a patient with congenital heart disease and heterotaxy, a disorder of left-right patterning, we previously identified the guanine nucleotide exchange factor, RAPGEF5. Here, we demonstrate that RAPGEF5 regulates left-right patterning via Wnt signaling. In particular, RAPGEF5 regulates the nuclear translocation of β-catenin independently of both β-catenin cytoplasmic stabilization and the importin β1/Ran-mediated transport system. We propose a model whereby RAPGEF5 activates the nuclear GTPases, Rap1a/b, to facilitate the nuclear transport of β-catenin, defining a parallel nuclear transport pathway to Ran. Our results suggest new targets for modulating Wnt signaling in disease states.

Pubmed ID: 29290587 RIS Download

Associated grants

  • Agency: NIH HHS, United States
    Id: S10 OD020142
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007223
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL124402
  • Agency: British Heart Foundation, United Kingdom
    Id: PG/17/79/33313
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD081379
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007205
  • Agency: Biotechnology and Biological Sciences Research Council, United Kingdom
    Id: BB/1021922/1
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD102186
  • Agency: NIH HHS, United States
    Id: S10 OD023598
  • Agency: Biotechnology and Biological Sciences Research Council, United Kingdom
    Id: BB/E013872/1
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001863
  • Agency: Medical Research Council, United Kingdom
    Id: MR/R014302/1

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Rap2A antibody (antibody)

RRID:AB_2177307

This polyclonal targets Rap2A antibody

View all literature mentions

Rap1, pAb (antibody)

RRID:AB_10617733

This polyclonal targets Rap1 pAb

View all literature mentions

H3-celegans (antibody)

RRID:AB_302613

This polyclonal targets H3

View all literature mentions

β-Actin Antibody (C4) (antibody)

RRID:AB_2714189

This monoclonal targets β-Actin

View all literature mentions

Anti-Active-beta-Catenin (anti-ABC), clone 8E7 (antibody)

RRID:AB_309887

This monoclonal targets Active-beta-Catenin

View all literature mentions

beta-catenin (H-102) (antibody)

RRID:AB_634603

This polyclonal targets CTNNB1

View all literature mentions

RAPGEF5 antibody [EPR6882] (antibody)

RRID:AB_11143604

This monoclonal targets RAPGEF5 antibody [EPR6882]

View all literature mentions

Xenbase (atlas)

RRID:SCR_003280

Data collection for Xenopus laevis and Xenopus tropicalis biology and genomics.

View all literature mentions